Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christophe Marchand

Showing results (61-70 of 110) with videos related to

Pageof 11
Sort By:
Nucleic Acids Research|September 26, 2006
Covalent binding of the natural antimicrobial peptide indolicidin to DNA abasic sitesChristophe Marchand, Krzysztof Krajewski, Hsiu-Fang Lee, et al.
Current Topics in Medicinal Chemistry|August 14, 2015
6,7-Dihydroxyisoindolin-1-one and 7,8-Dihydroxy-3,4-Dihydroisoquinolin- 1(2H)-one Based HIV-1 Integrase InhibitorsXue Zhi Zhao, Mathieu Metifiot, Steven J Smith, et al.
Molecules (Basel, Switzerland)|July 28, 2018
HIV-1 Integrase-Targeted Short Peptides Derived from a Viral Protein R SequenceXue Zhi Zhao, Mathieu Métifiot, Evgeny Kiselev, et al.
Molecular Cancer Therapeutics|March 1, 2006
A novel norindenoisoquinoline structure reveals a common interfacial inhibitor paradigm for ternary trapping of the topoisomerase I-DNA covalent complexChristophe Marchand, Smitha Antony, Kurt W Kohn, et al.
Journal of Medicinal Chemistry|June 6, 2014
4-amino-1-hydroxy-2-oxo-1,8-naphthyridine-containing compounds having high potency against raltegravir-resistant integrase mutants of HIV-1Xue Zhi Zhao, Steven J Smith, Mathieu Métifiot, et al.
Journal of Virology|March 16, 2004
Azido-containing diketo acid derivatives inhibit human immunodeficiency virus type 1 integrase in vivo and influence the frequency of deletions at two-long-terminal-repeat-circle junctionsEvguenia S Svarovskaia, Rebekah Barr, Xuechun Zhang, et al.
Journal of Medicinal Chemistry|January 30, 2014
Bicyclic 1-hydroxy-2-oxo-1,2-dihydropyridine-3-carboxamide-containing HIV-1 integrase inhibitors having high antiviral potency against cells harboring raltegravir-resistant integrase mutantsXue Zhi Zhao, Steven J Smith, Mathieu Métifiot, et al.
Journal of Medicinal Chemistry|December 22, 2007
2,3-dihydro-6,7-dihydroxy-1H-isoindol-1-one-based HIV-1 integrase inhibitorsXue Zhi Zhao, Elena A Semenova, B Christie Vu, et al.
Nucleic Acids Research|July 3, 2016
Selectivity for strand-transfer over 3'-processing and susceptibility to clinical resistance of HIV-1 integrase inhibitors are driven by key enzyme-DNA interactions in the active siteMathieu Métifiot, Barry C Johnson, Evgeny Kiselev, et al.
Antimicrobial Agents and Chemotherapy|October 31, 2007
Madurahydroxylactone derivatives as dual inhibitors of human immunodeficiency virus type 1 integrase and RNase HChristophe Marchand, John A Beutler, Antony Wamiru, et al.
Pageof 11

Showing results (61-70 of 110) with videos related to

Sort By:
Pageof 11
Nucleic Acids Research|September 26, 2006
Covalent binding of the natural antimicrobial peptide indolicidin to DNA abasic sitesChristophe Marchand, Krzysztof Krajewski, Hsiu-Fang Lee, et al.
Current Topics in Medicinal Chemistry|August 14, 2015
6,7-Dihydroxyisoindolin-1-one and 7,8-Dihydroxy-3,4-Dihydroisoquinolin- 1(2H)-one Based HIV-1 Integrase InhibitorsXue Zhi Zhao, Mathieu Metifiot, Steven J Smith, et al.
Molecules (Basel, Switzerland)|July 28, 2018
HIV-1 Integrase-Targeted Short Peptides Derived from a Viral Protein R SequenceXue Zhi Zhao, Mathieu Métifiot, Evgeny Kiselev, et al.
Molecular Cancer Therapeutics|March 1, 2006
A novel norindenoisoquinoline structure reveals a common interfacial inhibitor paradigm for ternary trapping of the topoisomerase I-DNA covalent complexChristophe Marchand, Smitha Antony, Kurt W Kohn, et al.
Journal of Medicinal Chemistry|June 6, 2014
4-amino-1-hydroxy-2-oxo-1,8-naphthyridine-containing compounds having high potency against raltegravir-resistant integrase mutants of HIV-1Xue Zhi Zhao, Steven J Smith, Mathieu Métifiot, et al.
Journal of Virology|March 16, 2004
Azido-containing diketo acid derivatives inhibit human immunodeficiency virus type 1 integrase in vivo and influence the frequency of deletions at two-long-terminal-repeat-circle junctionsEvguenia S Svarovskaia, Rebekah Barr, Xuechun Zhang, et al.
Journal of Medicinal Chemistry|January 30, 2014
Bicyclic 1-hydroxy-2-oxo-1,2-dihydropyridine-3-carboxamide-containing HIV-1 integrase inhibitors having high antiviral potency against cells harboring raltegravir-resistant integrase mutantsXue Zhi Zhao, Steven J Smith, Mathieu Métifiot, et al.
Journal of Medicinal Chemistry|December 22, 2007
2,3-dihydro-6,7-dihydroxy-1H-isoindol-1-one-based HIV-1 integrase inhibitorsXue Zhi Zhao, Elena A Semenova, B Christie Vu, et al.
Nucleic Acids Research|July 3, 2016
Selectivity for strand-transfer over 3'-processing and susceptibility to clinical resistance of HIV-1 integrase inhibitors are driven by key enzyme-DNA interactions in the active siteMathieu Métifiot, Barry C Johnson, Evgeny Kiselev, et al.
Antimicrobial Agents and Chemotherapy|October 31, 2007
Madurahydroxylactone derivatives as dual inhibitors of human immunodeficiency virus type 1 integrase and RNase HChristophe Marchand, John A Beutler, Antony Wamiru, et al.
Pageof 11